Regadenoson for Acute Vasoreactivity Testing in Pulmonary Hypertension

Summary

The purpose of this study is to see if Regadenoson may offer improved ease of use, single dose administration, and better tolerance for testing for pulmonary hypertension than iNO. You will be screened to make sure Regadenoson is safe for you with a clinical evaluation, blood tests, and an ECG.

Timeline

Start

2014-08

Primary completion

2017-05-25

Completion

2017-05-25

Outcome

Outcome not reported

Stopped: “PI left National Jewish Health”

Drugs

Indications